Alison L Blackman Emily L Heil Aaron S Devanathan Neha Sheth Pandit
10.3851/IMP3355
Antivir Ther
2020;25(2):115-119.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/32341207/
Anti-HIV Agents / pharmacokinetics Dideoxynucleosides / pharmacokinetics Extracorporeal Membrane Oxygenation / adverse effects HIV Infections / drug therapy Heterocyclic Compounds, 3-Ring / pharmacokinetics Lamivudine / pharmacokinetics Oxazines / pharmacokinetics Piperazines / pharmacokinetics Pyridones / pharmacokinetics
Anti-HIV Agents / pharmacokinetics Dideoxynucleosides / pharmacokinetics Extracorporeal Membrane Oxygenation / adverse effects HIV Infections / drug therapy Heterocyclic Compounds, 3-Ring / pharmacokinetics Lamivudine / pharmacokinetics Oxazines / pharmacokinetics Piperazines / pharmacokinetics Pyridones / pharmacokinetics Case Reports Research Support, N.I.H., Extramural Adult Anti-HIV Agents / administration & dosage Anti-HIV Agents / blood Anti-HIV Agents / therapeutic use Dideoxynucleosides / administration & dosage Dideoxynucleosides / blood Dideoxynucleosides / therapeutic use Drug Combinations Female HIV Infections / complications Heart-Lung Transplantation / adverse effects Heterocyclic Compounds, 3-Ring / administration & dosage Heterocyclic Compounds, 3-Ring / blood Heterocyclic Compounds, 3-Ring / therapeutic use Humans Intubation, Gastrointestinal Lamivudine / administration & dosage Lamivudine / blood Lamivudine / therapeutic use Oxazines / administration & dosage Oxazines / blood Oxazines / therapeutic use Piperazines / administration & dosage Piperazines / blood Piperazines / therapeutic use Pyridones / administration & dosage Pyridones / blood Pyridones / therapeutic use Anti-HIV Agents Dideoxynucleosides Drug Combinations Heterocyclic Compounds, 3-Ring Oxazines Piperazines Pyridones abacavir, lamivudine drug combination Lamivudine dolutegravir
PMC8351529
32341207
The effect of veno-arterial extracorporeal oxygenation and nasogastric tube administration on the pharmacokinetic profile of abacavir, lamivudine and dolutegravir: a case report
2020